SIX1 and neoplasm: To understand how Six1 deletion in cancer cells triggers an adaptive immune response to limit tumor growth, we performed transcriptomic RNA-sequencing (RNA-seq) analysis of WT and Six1−/− MCA205 tumor tissue samples  (GSE183580).